Biomillenia will be attending the Skin Microbiome Congress in Boston, Massachusetts (USA) from 30-31 May 2018! Furthermore, Biomillenia’s CEO, Dirk Loeffert, will be giving a talk entitled “Culturing the Previously ‘Unculturable’ Microbes” on 31 May 2018 at 11:00 AM. An abstract for this talk can be found below.
Development of next generation products requires access to novel beneficial strains and a more comprehensive understanding of the mechanism by which bacterial strains influence the human microbiota. Current state-of-the-art metagenomic and metabolomic approaches facilitate the study of the human microbiome; however, for these methods to ultimately enable modulation of the microbiota, such technologies will need to be able to discover, culture and undertake functional analysis of novel strains and variants. Biomillenia’s technology platform unlocks the microbiome’s potential by enabling microbe-based strains to be quickly and affordably phenotyped and isolated for product development.
If you’d like to meet us there to get to know our technology, discuss our product portfolio, or engage about joint development opportunities, please get in touch. We look forward to seeing you there!